BOCA RATON, Fla., July 14 MedeFile International, Inc. (OTC Bulletin Board: MDFI), a leader in personal portable electronic medical records management, announced today the addition of direct response marketing icon and emerging growth trends analyst Howard Mofshin to its Advisory Board.
Advertisement
Co-Founder of one of the fastest growing companies in America, "Cash4Gold", Mr. Mofshin is a noted entrepreneur, in-demand public speaker and successful venture capitalist whose innovations in direct response marketing have resulted in his being featured in numerous articles in nationally read publications such as AdAge, Smart Business, USA Today and The Washington Post.
Advertisement
Nominated for Ernst and Young's Entrepreneur Of The Year Award after engineering the Kellogg Award-winning "Cash4Gold" Super Bowl commercial featuring MC Hammer and Ed McMahon- the first direct response commercial ever to reach such a large audience- Howard is a frequent speaker at direct response and venture growth conferences around the world and is widely hailed for his talent at identifying emerging growth trends in business. Mr. Mofshin continues to be a sought after speaker at both direct response marketing and venture growth events.
Mr. Mofshin brings his expertise in direct response marketing and his venture capital credentials to MedeFile with the intention of further developing and effectively executing MedeFile's long term marketing agenda.
"Identifying emerging fields in business of potentially massive growth is a big part of what I do, " said Mr. Mofshin, "and Personal Health Records is a field that is clearly exploding onto the healthcare scene. I look forward to bringing my experience in direct response marketing to bear on MedeFile's already impressive marketing strategy in order to help MedeFile reach as broad a spectrum of customers as possible."
Kevin Hauser, Director, Business Development of MedeFile, said, "Howard Mofshin is a peerless marketing innovator whose experience in the field of direct response is unparalleled. Howard is an expert in bringing great products and services to massive numbers of people." Mr. Hauser added that, "having Howard on our team can potentially result in a level of growth previously unforeseen within MedeFile."
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
CONTACT:
MedeFile
561-912-3393
[email protected]
SOURCE MedeFile International, Inc.
